CTRI/2008/091/000014已完成3 期
Effect of liraglutide or glimepiride added to metformin on glycaemic control in subjects with type 2 diabetes
ovo Nordisk AS0 个研究点目标入组 896 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 896
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Type 2 diabetes
- •2. Subjects diagnosed with type 2 diabetes and treated with one or more oral antidiabetic drugs (OADs) for the last 3 months
- •3. HbA1c: 7.0-11.0% (both incl.) for subjects on OAD alone
- •4. HbA1c: 7.0-10.0 % (both incl.) for subjects on OAD combination therapy
- •5. BMI less than 45.0 kg/m2
- •6.Age -above 18 Years
排除标准
- •1. Treatment with insulin within the last 3 months prior to the trial
- •2. Impaired liver or/and renal function
- •3. Significant cardiovascular disease over the last 6 months
- •4. Known retinopathy or maculopathy
- •5. Recurrent major hypoglycaemia or hypoglycaemic unawareness
研究者
相似试验
招募中
1 期
Investigating the effect of empagliflozin and melijent in chronic kidney failure patientsDiabetic patients.Type 2 diabetes mellitus with kidney complicationsE11.2IRCT20230607058409N1Shahid Beheshti University of Medical Sciences150
已完成
不适用
Effect of the combination therapy of liraglutide, a GLP-1 receptor analog, and IDegAsp in patients with type 2 diabetesType2 diabetesJPRN-UMIN000033511Yokohama City University Medical Center Department of Endocrinology and Diabetes60
已完成
3 期
Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT00614120Novo Nordisk A/S929
招募中
4 期
The effect of liraglutide on MMC activity, gastrointestinal hormones, hunger ratings and ad libitum food intake in healthy volunteers.Obesity2024-518641-21-00UZ Leuven15
已完成
4 期
Study of combination of vildagliptin with metformin and glimepiride with metformin in type2 diabetic patientsCTRI/2022/01/039090avreet Kaur80